RXST Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 Jul 2024 @ 16:00):
Our systems believe the stock currently is undervalued by 0.19% compare to its pairs and should correct upwards.

Stats
Today's Volume	410 491
Average Volume	427 267
Market Cap	2.21B
EPS	$-0.250 ( Q1 \| 2024-05-06 )
Next earnings date	( $-0.110 ) 2024-08-05
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-45.81 (Sector) 42.63 (Industry) 0
ATR14	$0.0690 (0.12%)

AEMD -9.77%

AFIB -12.68%

AHCO -2.70%

AHPI 0.00%

ALGN -1.16%

ANIK 2.05%

APEN 0.00%

APYX -2.99%

ARAY -3.30%

ATEC -4.50%

AXDX 0.00%

AXGN 6.49%

AXNX 0.10%

AZYO 2.05%

BBLG -2.44%

BIOL 7.80%

BJDX 0.87%

BMRA 0.07%

BRKR -2.32%

BSGM -0.06%

BWAY -3.46%

CERS -2.27%

CFMS 0.44%

CLPT -1.11%

CODX 0.80%

CSII 0.15%

CTKB 0.54%

CTSO -0.43%

CUTR -0.66%

CVRX -2.34%

DCTH -1.31%

DXCM -1.07%

DYNT -16.23%

EAR -4.10%

ECOR 0.00%

EDAP -4.04%

ESTA -4.62%

FONR 0.88%

HJLI -1.98%

HSDT -1.15%

HSKA 0.00%

HYPR 8.07%

IART -0.58%

ICAD -2.69%

ICCM -0.68%

IINN -11.59%

INGN -3.69%

INMD -2.03%

IRIX -3.24%

IRMD -1.14%

IRTC -1.11%

ISO 0.00%

ITMR 0.00%

KIDS -1.91%

LHDX 0.00%

LIVN -0.62%

LNSR -1.22%

LUCD -3.78%

LUNG -1.58%

MASS -7.38%

MDGS 10.28%

MOTS -16.81%

MOVE 5.78%

MSON 0.00%

NAOV -0.10%

NARI 4.24%

NMRD 33.33%

NNOX -2.59%

NPCE -3.17%

NTUS 0.00%

NURO -1.62%

NUVA -2.24%

NUWE -3.18%

NVCN 0.00%

NVNO -2.48%

OBLN -5.86%

OFIX -2.87%

OM -4.16%

PACB -12.41%

PAVM -6.26%

PETV -23.08%

PODD -2.79%

PRCT 1.28%

PROF 2.01%

QIPT -1.24%

QTRX -4.01%

RCEL -2.53%

RPID 3.05%

RSLS 3.86%

RWLK 6.07%

RXST -5.60%

SGHT -5.40%

SIBN -0.23%

SIEN -18.69%

SILK -0.33%

SINT -5.21%

SOLY 0.00%

SRDX -0.33%

SRGA 0.00%

SRTS -6.47%

SWAV 0.00%

TBIO 5.75%

TCMD -4.44%

TELA -4.47%

THMO -16.67%

TIVC -1.19%

TLIS -4.20%

TMCI -2.41%

TMDI 0.00%

TMDX -0.29%

TNDM -2.08%

TNON 18.05%

UFPT 9.56%

VERO -8.17%

VIVE 0.00%

VMD -2.29%

VRAY 0.00%

VREX -2.99%

VVOS 6.31%

XAIR 18.39%

XENT 0.00%

ZIMV -0.66%

Insider Trading

Date	Person	Action	Amount	type
2024-06-14	Andrews Julie	Sell	11 940	Common Stock
2024-06-14	Andrews Julie	Sell	3 685	Common Stock
2024-06-06	Warner Robert Keith	Buy	2 554	Common Stock
2024-06-06	Palmisano Robert J	Buy	2 554	Common Stock
2024-06-06	Maniar Shweta	Buy	2 554	Common Stock

INSIDER POWER
5.90
Last 100 transactions
Buy: 668 683 \| Sell: 609 612

Correlation (AI algo v.1.1b): Undervalued: 0.19% $56.91 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: -0.60 (weak negative)

Short: -0.89 (strong negative)

Signal:(23.063) Be Aware. Possible trading coming up! (swing)

RxSight, Inc. Correlation

10 Most Positive Correlations
TUR	0.882
CGEM	0.876
STEP	0.858
INBKZ	0.855
APXI	0.842
SILK	0.833
BDTX	0.832
INTE	0.829
HYAC	0.823
OXSQ	0.822

10 Most Negative Correlations
UTRS	-0.907
GLBS	-0.878
SBAC	-0.867
WINT	-0.862
NAVI	-0.856
EGBN	-0.853
SSBI	-0.853
WVVIP	-0.849
RVSB	-0.847
IGOV	-0.844

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

RxSight, Inc. Correlation - Currency/Commodity

0.13
( neutral )

0.38
( neutral )

0.00
( neutral )

0.55
( weak )

0.00
( neutral )

-0.39
( neutral )

RxSight, Inc. Financials

Annual	2023
Revenue:	$89.08M
Gross Profit:	$53.77M (60.36 %)
EPS:	$-1.410

FY	2023
Revenue:	$89.08M
Gross Profit:	$53.77M (60.36 %)
EPS:	$-1.410

FY	2022
Revenue:	$49.01M
Gross Profit:	$21.33M (43.52 %)
EPS:	$-2.41

FY	2021
Revenue:	$22.59M
Gross Profit:	$4.52M (19.99 %)
EPS:	$-2.59

Financial Reports:

No articles found.

RxSight, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

RxSight, Inc.

RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.